Your browser doesn't support javascript.
loading
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial.
Gnanenthiran, Sonali R; Wang, Nelson; Di Tanna, Gian Luca; Salam, Abdul; Webster, Ruth; de Silva, H Asita; Guggilla, Rama; Jan, Stephen; Maulik, Pallab K; Naik, Nitish; Selak, Vanessa; Thom, Simon; Prabhakaran, Dorairaj; Schutte, Aletta E; Patel, Anushka; Rodgers, Anthony.
Affiliation
  • Gnanenthiran SR; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Wang N; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Di Tanna GL; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Salam A; The George Institute for Global Health, Hyderabad, India University of New South Wales, Sydney, New South Wales, Australia.
  • Webster R; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • de Silva HA; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Guggilla R; Clinical Trials Unit, Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
  • Jan S; Department of Population Medicine and Lifetsyle Diseases Prevention, Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Bialystok, Poland.
  • Maulik PK; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Naik N; The George Institute for Global Health, Hyderabad, India University of New South Wales, Sydney, New South Wales, Australia.
  • Selak V; All India Institute of Medical Sciences, New Delhi.
  • Thom S; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand.
  • Prabhakaran D; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Schutte AE; Centre for Chronic Disease Control and Public Health Foundation, New Delhi, India.
  • Patel A; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Rodgers A; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
JAMA Cardiol ; 7(6): 645-650, 2022 06 01.
Article in En | MEDLINE | ID: mdl-35416909
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: JAMA Cardiol Year: 2022 Document type: Article Affiliation country: